Plain-English translation of NCT06208397 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a specialized MRI technique called MR elastography can help doctors predict how your liver tumor is growing — specifically, the pattern at the edge where cancer meets healthy liver tissue. Right now, doctors can only see this growth pattern after surgery by looking at tissue samples under a microscope. This study hopes to see it safely and non-invasively before your surgery, which could help your doctors choose the best treatment plan for you.
Colorectal cancer that has spread to the liver has very different outcomes depending on how the tumor grows at its edges. Some growth patterns respond better to certain treatments than others. If doctors could predict your tumor's growth pattern before surgery — instead of after — they could plan smarter, personalized treatment that might help you live longer.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a specialized MRI scan (called MR elastography) the day before your scheduled liver surgery. This scan is non-invasive and takes place at the hospital — you simply lie still while the machine takes detailed images of your tumor and the surrounding liver tissue. After your surgery, doctors will examine your tumor tissue under a microscope as they normally would, and researchers will compare what the MRI showed to what they find in the tissue to see if the scan can accurately predict growth patterns.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China
Sponsor
Shengjing Hospital
Enrollment target
~50 participants
Started
December 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yu Shi, M.D.
Shengjing Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.